VIMIAN.ST Stock — Price, Charts & Analysis

Vimian Group AB (publ) (VIMIAN.ST) has a trailing P/E of 45.65x and a forward P/E of 26.43x. This places VIMIAN.ST in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

VIMIAN.ST trades with 45.65x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether VIMIAN.ST looks overvalued or undervalued.

VIMIAN.ST's P/E of 45.65x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

VIMIAN.ST's trailing EPS is SEK 0.77 and forward EPS is SEK 1.33. Reported earnings growth is 0.20%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Vimian Group AB (publ) generated for each share. VIMIAN.ST's trailing EPS is SEK 0.77, and investors usually prefer EPS that is positive and growing over time.

Vimian Group AB (publ) has a market cap of SEK 18.56B, making VIMIAN.ST a large-cap stock based on the current market value shown on Worldtickers.

VIMIAN.ST's latest stock price on Worldtickers is SEK 35.15. The latest move is -SEK 0.10 or -0.28%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

VIMIAN.ST's quote includes a latest price of SEK 35.15. The market open is SEK 35.30. Previous close is SEK 35.25. The intraday range is SEK 34.90 to SEK 35.45.

VIMIAN.ST is down in the latest quote, with a move of -SEK 0.10 or -0.28%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

VIMIAN.ST generated SEK 450.90M in trailing revenue. Revenue growth is 16.60%, which helps show whether demand is expanding or slowing.

VIMIAN.ST's revenue growth is 16.60%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, VIMIAN.ST shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SEK 36.80M.

Gross margin is 68.82%. Margins show how efficiently Vimian Group AB (publ) turns revenue into profit.

Vimian Group AB (publ) carries SEK 278.80M and holds SEK 51.60M in cash.

VIMIAN.ST holds SEK 51.60M on its balance sheet.

VIMIAN.ST's book value per share is SEK 1.37.

Institutions hold 86.07% of VIMIAN.ST shares. Insiders hold 6.45% of shares. Ownership mix helps investors understand how much of Vimian Group AB (publ) is held by professional investors and company insiders.

VIMIAN.ST has 527.06M shares outstanding. Float shares are 187.35K. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for VIMIAN.ST, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for VIMIAN.ST is SEK 1.33. Earnings growth is 0.20%. Revenue growth is 16.60%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

VIMIAN.ST's trailing EPS is SEK 0.77. Forward EPS is SEK 1.33. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

VIMIAN.ST is in the Healthcare sector. Its earnings multiple is 45.65x. Its latest displayed growth metric is 16.60%. Compare these figures with sector peers before deciding whether Vimian Group AB (publ) is stronger or weaker than average.

VIMIAN.ST trades at SEK 35.15. The stock trades at 45.65x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Vimian Group AB (publ)'s fundamentals.

VIMIAN.ST risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 1.19, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

VIMIAN.ST should be compared with companies in Diagnostics & Research. Its earnings multiple is 45.65x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Vimian Group AB (publ) (VIMIAN.ST) operates in Healthcare, specifically Diagnostics & Research. Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and compani

VIMIAN.ST trades on Stockholm. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

VIMIAN.ST stock is priced in SEK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Vimian Group AB (publ)'s official website listed on Worldtickers is vimian.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Vimian Group AB (publ) employs about 1.3K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Vimian Group AB (publ) is headquartered in Stockholm, Sweden. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

VIMIAN.ST is in the Healthcare sector and the Diagnostics & Research industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

VIMIAN.ST has traded between SEK 24.18 and SEK 35.90 over the past 52 weeks. At SEK 35.15, it is 2.09% below the high and 45.37% above the low. The 52-week range helps gauge long-term price momentum.

VIMIAN.ST is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is SEK 32.37 and its 200-day moving average is SEK 29.63.

VIMIAN.ST's RSI is 61.20. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

VIMIAN.ST's latest RSI reading is 61.20, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for VIMIAN.ST is near SEK 33.15. Key resistance is near SEK 35.90. Breaks above resistance or below support can change the short-term technical setup.

VIMIAN.ST's nearest reported support level is SEK 33.15. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

VIMIAN.ST's nearest reported resistance level is SEK 35.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

VIMIAN.ST trades about 374.52K shares daily on average. The latest displayed volume is 108.14K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

VIMIAN.ST's MACD is -0.15, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

VIMIAN.ST is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 61.20 (neutral). MACD is bearish. Nearest support is around SEK 33.15. Resistance is around SEK 35.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SEK 34.81 (0.98% from price). MA50 is SEK 32.37 (8.60% from price). MA200 is SEK 29.63 (18.63% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. VIMIAN.ST's MA20 is SEK 34.81. MA50 is SEK 32.37. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

VIMIAN.ST's pivot is near SEK 35.13. Support is near SEK 33.15. Resistance is near SEK 35.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for VIMIAN.ST is near SEK 33.85. These levels help define risk and possible follow-through zones after a breakout or breakdown.

VIMIAN.ST's Bollinger range is roughly SEK 33.72 to SEK 35.90. Band width is near 6.26%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

VIMIAN.ST's ATR-based typical daily range is about 2.57%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 108.14K shares. Average volume is about 374.52K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

VIMIAN.ST's all-time high shown on Worldtickers is SEK 123.40. Its all-time low is SEK 20.08. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

VIMIAN.ST has a beta of 1.19, meaning it has historically been more volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.